An official website of the United States government
Home
Name
Eflornithine
Alternate Names
Alpha-DFMO HCl
alpha-Difluoromethylornithine
Alpha-Difluoromethylornithine Hydrochloride
DFMO
Difluoromethylornithine
Eflornithine Hcl
eflornithine hydrochloride
Eflornithine Monohydrochloride
MDL-71782
MDL-71782A
Monohydrate
Ornidyl
RMI 71782
Vaniqa
Iwilfin
Abbreviations
DFMO (HCl)
Category
Chemotherapy
Subcategory
Miscellaneous agent
NSC Number
337250
Primary Site
Histology
None
Remarks
December 13, 2023 the FDA eflornithine to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma (HRNB) who have demonstrated at least a partial response to prior multiagent, multimodality therapy including anti-GD2 immunotherapy.
Coding
This drug should be coded
